SenesTech Q3 revenue rises 59%; net loss hits $1.96M
E-commerce revenue accounted for approximately 71% of Q3 sales, while subscription revenue increased 234% year over year.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K
Rhea-AI Filing Summary
SenesTech, Inc. reported third-quarter 2026 revenue of $1.097 million, up 59% from $690,000 a year earlier and 42% from $770,000 in the second quarter. E-commerce revenue increased 337% year over year and represented approximately 71% of quarterly revenue; subscription revenue increased 234%. Direct B2B revenue increased 2% year over year and 19% sequentially. Evolve revenue was $979,000, and ContraPest revenue was $118,000.
Gross profit reached $796,000, up 84% year over year, while gross margin was 72.6% versus 62.8%. Net loss was $1.956 million, compared with $1.298 million a year earlier; adjusted EBITDA loss was $1.428 million versus $1.140 million. Net cash used in operating activities was $1.322 million in the quarter, and cash and cash equivalents were $3.951 million as of September 30, 2026. The company added two salespeople to the team led by Executive Vice President of Sales Jack Karabees and expects two more hires by year-end. It began offering assessment services to B2B customers in July.
2 points · 0 major0 major · 2 points
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- Moderate pointRevenue increased 59% year over year to $1.097 million.
- Moderate pointGross profit increased 84% year over year to $796,000.
Negative
- Moderate pointNet loss was $1.956 million, compared with $1.298 million in Q3 2025.
- Moderate pointAdjusted EBITDA loss was $1.428 million, compared with $1.140 million in Q3 2025.
Filing Explained
The Q3 cash-flow statement reports net proceeds from common-stock issuances, so shares were issued during the quarter. Issuing shares increases the share count and reduces existing holders’ percentage ownership, but this proceeds figure does not size that ownership change.
8-K Event Classification
2 items: 2.02, 9.01
2 items
Item 2.02
Results of Operations and Financial Condition
Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
Revenue: $1.097 million
E-commerce revenue growth: 337% year over year
Gross profit: $796,000
+5 more
8 metrics
Revenue
$1.097 million
Q3 2026; up 59% year over year
E-commerce revenue growth
337% year over year
Q3 2026
Gross profit
$796,000
Q3 2026; up 84% year over year
Gross margin
72.6%
Q3 2026; compared with 62.8% in Q3 2025
Net loss
$1.956 million
Q3 2026; compared with $1.298 million in Q3 2025
Adjusted EBITDA loss
$1.428 million
Q3 2026; compared with $1.140 million in Q3 2025
Net cash used in operating activities
$1.322 million
Three months ended September 30, 2026
Cash and cash equivalents
$3.951 million
As of September 30, 2026
Key Terms
Adjusted EBITDA, non-GAAP measure, integrated pest management (IPM), held-to-maturity investments, +1 more
5 terms
Adjusted EBITDA financial
"Adjusted EBITDA is a non-GAAP measure"
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
non-GAAP measure financial
"This measure has been included because management believes"
A non-GAAP measure is a company-crafted financial metric that adjusts or excludes items from standard accounting numbers to highlight what management sees as the business’s core performance. Investors use these figures like a filtered photo to reveal trends or cash flow drivers that raw accounting totals might hide, but because companies decide which items to remove, these measures should be compared with standard statements to avoid being misled.
integrated pest management (IPM) technical
"as part of an integrated pest management (IPM) program"
A structured, decision-based approach to controlling crop pests and disease that combines monitoring, prevention, and a hierarchy of control tactics—biological (natural predators), cultural (crop rotation, sanitation), physical/mechanical (traps, barriers), and chemical (pesticides). IPM relies on regular scouting and defined action thresholds to determine when controls are needed, favors non-chemical methods first, and uses targeted pesticide applications only when other measures are insufficient. It is a management strategy, not a guarantee of zero pest use; its goal is to achieve acceptable control while minimizing economic, human health, and environmental impacts.
held-to-maturity investments financial
"Purchase of held-to-maturity investments"
Debt securities that an entity has the positive intent and ability to hold until their contractual maturity date; they are accounted for at amortized cost rather than fair value. Held-to-maturity classification applies only to debt instruments (not equity), requires the holder to plan and be able to keep them to maturity, and means periodic interest is recognized using the effective interest method while unrealized gains or losses from changes in market price are generally not recognized except for impairment or when the holder no longer meets the intent-and-ability condition.
deferred revenue financial
"Deferred revenue"
Cash a company has already received for goods or services it has promised but not yet delivered; it's recorded as a liability because the company still owes that product, service, or future revenue recognition. For investors, deferred revenue signals upcoming work or deliveries that will convert into reported sales over time and affects short-term obligations, cash flow quality, and how quickly a firm can grow recognized revenue—think of it like prepaid subscriptions or gift cards a business must honor later.
Earnings Snapshot
Revenue: $1.097 million
Q3 2026
Revenue
$1.097 million
Up 59% year over year
Gross profit
$796,000
Up 84% year over year
Gross margin
72.6%
Compared with 62.8% in Q3 2025
Net loss
$1.956 million
Compared with $1.298 million in Q3 2025
Adjusted EBITDA loss
$1.428 million
Compared with $1.140 million in Q3 2025
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How much revenue did SNES report in Q3 2026?
SenesTech reported $1.097 million in revenue for Q3 2026, up 59% from $690,000 in Q3 2025 and 42% from $770,000 in Q2 2026.
What was SNES's net loss in Q3 2026?
SenesTech reported a $1.956 million net loss in Q3 2026, compared with a $1.298 million net loss in Q3 2025. Adjusted EBITDA loss was $1.428 million, compared with $1.140 million a year earlier.
What assessment services did SenesTech begin offering?
SenesTech began offering B2B assessment services in July. Customers can choose an assessment performed by the company or deploy its tracking products themselves, with results analyzed using SenesTech's internally developed AI tool.
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): November 10, 2026
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||||||||||||
| (Address of principal executive offices) | (Zip Code) | |||||||
Registrant’s telephone number, including area code: (928 ) 779-4143
N/A | ||
(Former name or former address, if changed since last report) | ||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
The | ||||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition.
On November 10, 2026, we announced our financial results for the third quarter ended September 30, 2026. A copy of our press release announcing these financial results and certain other information is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.
The information in this Item 2.02 (including Exhibit 99.1) shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.
We do not have, and expressly disclaim, any obligation to release publicly any updates or any changes in our expectations or any changes in events, conditions, or circumstances on which any forward-looking statement regarding the foregoing subject matter is based.
Item 9.01. Financial Statements and Exhibits.
(d)Exhibits.
| Exhibit Number | Description | |||||||
| 99.1 | Press Release dated November 10, 2026 (furnished herewith). | |||||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). | |||||||
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: November 10, 2026 | SENESTECH, INC. | |||||||
| By: | /s/ Thomas C. Chesterman | |||||||
| Thomas C. Chesterman | ||||||||
| Executive Vice President, Chief Financial Officer, Treasurer and Secretary | ||||||||
Exhibit 99.1
SenesTech Reports Record Q3 2026 Revenue with 59% Year-Over-Year Growth
Revenue increased 42% sequentially as e-commerce and subscriptions expanded;
Gross profit reached a record $796,000
SURPRISE, Ariz., November 10, 2026 (GLOBE NEWSWIRE) — SenesTech, Inc. (NASDAQ: SNES), an innovator in rodent control, today announced financial results for the third quarter ended September 30, 2026.
Q3 2026 Financial Highlights
•Total revenue increased 42% sequentially to a record $1.097 million in Q3 2026, compared to $770,000 in Q2 2026, and increased 59% compared to $690,000 in Q3 2025. This was the second consecutive quarterly revenue record and the first quarter above $1 million, consistent with the preliminary revenue of approximately $1.1 million announced on October 15, 2026.
•E-commerce revenue increased 52% sequentially and 337% year over year, representing approximately 71% of total Q3 revenue.
•Subscription revenue increased 53% sequentially and 234% year over year. Combined subscribers across Amazon and the Company’s website increased 72% compared to Q2 2026, strengthening the recurring revenue base.
•Direct B2B revenue increased 19% sequentially and 2% year over year. Sequential growth was driven by process changes to the Company’s B2B efforts, which drove growth in the pest management, government and commercial verticals.
•Evolve® revenue increased 67% year over year to $979,000 and represented 89% of product revenue. ContraPest® revenue increased 13% year over year to $118,000, driven by higher refill sales.
•Gross profit increased 40% to a record $796,000 in Q3 2026, compared to $567,000 in Q2 2026, and increased 84% compared to $433,000 in Q3 2025.
•Gross margin was 72.6% in Q3 2026, compared to 73.6% in Q2 2026 and 62.8% in Q3 2025.
•Net loss for Q3 2026 was $2.0 million, compared to $1.8 million in Q2 2026, and $1.3 million in Q3 2025.
•Adjusted EBITDA loss was $1.4 million in Q3 2026, compared to $1.4 million in Q2 2026, and $1.1 million in Q3 2025.
•Cash and cash equivalents decreased $1.1 million during Q3 2026 to $4.0 million.
•Net cash used in operating activities declined each quarter in 2026, falling to $1.3 million in Q3 from $1.7 million in Q2 2026 and $1.9 million in Q1 2026.
Recent Operational and Strategic Highlights
•Amazon Revenue and Subscriptions Continue to Grow: Amazon revenue increased each month of Q3, bringing in new customers and expanding the recurring subscription base.
•B2B Sales Team Expanded: The Company added two salespeople, bringing the team under Executive Vice President of Sales Jack Karabees to four, with two additional hires expected by year end. The team is focused on building repeat business across targeted domestic verticals.
•E-commerce Reach Expanded Through Grove Collaborative: SenesTech added Grove Collaborative as a third-party e-commerce channel, bringing Evolve® to an engaged base of consumers focused on sustainability.
•Assessment and Monitoring Services Launched for B2B Customers: In July, SenesTech began offering assessment services to help B2B customers measure rodent activity and understand the scope of an infestation. Customers can choose an assessment performed by SenesTech or deploy the Company’s tracking products themselves, with results analyzed using SenesTech’s internally developed AI tool. These services complement existing implementation and deployment services and are expected to provide an additional revenue opportunity.
•Municipal Results Support Broader Adoption: Chicago’s Wicker Park Bucktown program, which incorporated SenesTech’s assessment services and Evolve® into an integrated pest management approach, reduced average rat activity intensity by 88% over 12 months. Evolve has expanded to six Chicago-area Special Service Areas and wards. In Swampscott, Massachusetts, Evolve Rat, combined with sanitation and waste management improvements, helped reduce measured rodent activity by 43% over six months.
•Sandstrom Partners Engaged to Support Branding and Marketing: SenesTech engaged Sandstrom Partners, a Portland, Oregon, brand development firm whose clients have included Nike, Target and Coca-Cola, as a strategic advisor on marketing and branding. An early priority is helping retain Amazon customers and attract new customers by more clearly communicating how the Company’s rodent birth control products work.
Management Commentary
“SenesTech delivered a milestone third quarter, exceeding $1 million in quarterly revenue for the first time and setting new records for revenue, gross profit and subscription customers,” said Michael Edell, President and Chief Executive Officer of SenesTech. “These results demonstrate the momentum we are building. With e-commerce delivering strong growth and our expanded B2B sales team pursuing new opportunities, we are excited about the foundation we are establishing for continued growth.
“Our e-commerce business continues to lead the way, with revenue increasing 52% sequentially, driven by another record quarter on Amazon. Across Amazon and our website, combined subscription customers increased 72% sequentially, while subscription revenue grew 53%. We are reaching more customers and building ongoing relationships that support repeat purchases, greater revenue visibility and long-term customer value.
“We see direct B2B as the next significant driver of growth alongside our expanding e-commerce business. By expanding the sales team, we have increased our capacity to pursue opportunities across our targeted verticals. Direct B2B revenue increased 19% sequentially, and we believe our growing brand awareness, broader customer adoption and focused sales efforts position us to build on that progress,” Mr. Edell concluded.
“Record gross profit of $796,000 and a gross margin of 72.6% highlight the strength of our business model as revenue scales,” said Tom Chesterman, Chief Financial Officer of SenesTech. “Our focus is on translating this commercial momentum into sustained financial progress. We are also putting our cash to work more efficiently: excluding non-cash items such as stock-based and other non-cash compensation, depreciation and straight-line rent, sales and marketing has grown as a share of operating expenses compared to the third quarter of 2025, while general and administrative spending has declined as a share.”
Use of Non-GAAP Measures
Adjusted EBITDA is a non-GAAP measure and is not intended to be a substitute for those financial measures reported in accordance with GAAP. This measure has been included because management believes that, when considered together with the GAAP figures, it provides meaningful information related to operating
2
performance and liquidity trends. We use these non-GAAP financial measures as part of our overall assessment of our performance, including the preparation of our annual operating budget and quarterly forecasts, to evaluate the effectiveness of our business strategies, and to communicate with our board of directors concerning our financial performance. These adjustments may be calculated by us differently than other companies that disclose measures with the same or similar terms. See our attached financials for a reconciliation of the non-GAAP measures to the nearest GAAP measure.
Conference Call Details
Date: Tuesday, November 10, 2026.
Time: 5 p.m. ET.
Call-in Information: Interested parties can access the live teleconference by dialing 1-844-308-3351 or 1-412-317-5407.
Webcast: https://app.webinar.net/EM53kOPaJDx.
Webcast Replay: Available for 90 days on the Company’s website.
About SenesTech
SenesTech is the leader in rodent birth control and sustainable rodent population management, with a mission to support a healthier environment through the responsible management of animal pest populations. The Company’s Evolve® and ContraPest® fertility control solutions, along with its assessment and monitoring services, target reproduction to help reduce rodent populations. SenesTech serves consumer and professional markets with proven approaches that can be used independently or as part of an integrated pest management (IPM) program.
For more information, visit https://senestech.com/.
Safe Harbor Statement
This press release contains “forward-looking statements” within the meaning of federal securities laws, and we intend that such forward-looking statements be subject to the safe harbor created thereby. Such forward-looking statements include, without limitation, statements regarding expected growth in e-commerce, subscription and direct B2B revenue; the planned addition of two salespeople by year end; the anticipated benefits of the Company’s third-party e-commerce relationship with Grove Collaborative; the expansion of municipal adoption of Evolve®; the anticipated benefits of, and revenue opportunity from, the Company’s assessment services; the anticipated benefits of the Company’s engagement of Sandstrom Partners, including improved customer retention and acquisition; and the Company’s ability to use cash more efficiently.
Forward-looking statements may describe future expectations, plans, results or strategies and are often, but not always, made through the use of words such as “believe,” “may,” “future,” “plan,” “will,” “should,” “expect,” “anticipate,” “eventually,” “project,” “estimate,” “continuing,” “intend” and similar words or phrases. You are cautioned that such statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements. Such factors include, among others, the Company’s ability to sustain revenue growth across its e-commerce and B2B channels; its reliance on Amazon and other third-party platforms; its ability to retain and grow subscribers; the ability of its sales team to generate direct B2B revenue; the continued adoption of its products by municipalities; market acceptance of its assessment services and its ability to deliver them profitably; the effectiveness of its marketing and branding initiatives; the Company’s history of losses and need for additional capital to fund operations; its ability to manage operating expenses and cash; competition; regulatory developments affecting its products, including EPA and state registration requirements; supply chain and manufacturing risks; general economic conditions; and other factors and risks identified from time to time in our filings with the Securities and
3
Exchange Commission, including the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management’s assumptions and estimates as of such date. Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.
CONTACT:
Investors: Robert Blum, Lytham Partners, LLC, (602) 889-9700, senestech@lythampartners.com
Company: Tom Chesterman, Chief Financial Officer, SenesTech, Inc., (928) 779-4143
4
SENESTECH, INC.
BALANCE SHEETS
(In thousands, except share and per share data)
(Unaudited)
| September 30, 2026 | December 31, 2025 | ||||||||||
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ | 3,951 | $ | 7,575 | |||||||
| Short-term investments | — | 994 | |||||||||
| Accounts receivable, net | 247 | 201 | |||||||||
| Inventory | 966 | 994 | |||||||||
| Prepaid expenses and other current assets | 398 | 297 | |||||||||
| Total current assets | 5,562 | 10,061 | |||||||||
| Right to use asset, operating lease | 2,211 | 2,336 | |||||||||
| Property and equipment, net | 334 | 410 | |||||||||
| Other noncurrent assets | 36 | 36 | |||||||||
| Total assets | $ | 8,143 | $ | 12,843 | |||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | $ | 357 | $ | 183 | |||||||
| Accrued expenses | 615 | 383 | |||||||||
| Current portion of operating lease liability | 151 | 139 | |||||||||
| Current portion of notes payable | 65 | 61 | |||||||||
| Deferred revenue | 45 | 32 | |||||||||
| Total current liabilities | 1,233 | 798 | |||||||||
| Operating lease liability, less current portion | 2,217 | 2,332 | |||||||||
| Notes payable, less current portion | 95 | 145 | |||||||||
| Total liabilities | 3,545 | 3,275 | |||||||||
| Stockholders’ equity: | |||||||||||
| Common stock | 5 | 5 | |||||||||
| Additional paid-in capital | 152,924 | 152,043 | |||||||||
| Accumulated deficit | (148,331) | (142,480) | |||||||||
| Total stockholders’ equity | 4,598 | 9,568 | |||||||||
| Total liabilities and stockholders’ equity | $ | 8,143 | $ | 12,843 | |||||||
5
SENESTECH, INC.
STATEMENTS OF OPERATIONS
(In thousands, except share and per share data)
(Unaudited)
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Revenues, net | $ | 1,097 | $ | 690 | $ | 2,360 | $ | 1,800 | |||||||||||||||
| Cost of sales | 301 | 257 | 659 | 645 | |||||||||||||||||||
| Gross profit | 796 | 433 | 1,701 | 1,155 | |||||||||||||||||||
| Operating expenses: | |||||||||||||||||||||||
| Research and development | 418 | 400 | 1,217 | 1,245 | |||||||||||||||||||
| Sales and marketing | 1,082 | 425 | 2,218 | 1,277 | |||||||||||||||||||
| General and administrative | 1,287 | 955 | 4,238 | 3,257 | |||||||||||||||||||
| Total operating expenses | 2,787 | 1,780 | 7,673 | 5,779 | |||||||||||||||||||
| Loss from operations | (1,991) | (1,347) | (5,972) | (4,624) | |||||||||||||||||||
| Interest income, net | 35 | 49 | 121 | 45 | |||||||||||||||||||
| Net loss | $ | (1,956) | $ | (1,298) | $ | (5,851) | $ | (4,579) | |||||||||||||||
| Weighted average shares outstanding — basic and diluted | 5,420,899 | 4,668,009 | 5,329,923 | 2,619,841 | |||||||||||||||||||
| Loss per share — basic and diluted | $ | (0.36) | $ | (0.28) | $ | (1.10) | $ | (1.75) | |||||||||||||||
6
SENESTECH, INC.
STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Cash flows from operating activities: | |||||||||||||||||||||||
| Net loss | $ | (1,956) | $ | (1,298) | $ | (5,851) | $ | (4,579) | |||||||||||||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||||||||||||||||||||
| Stock-based compensation | 276 | 47 | 481 | 228 | |||||||||||||||||||
| Depreciation and amortization | 32 | 29 | 94 | 103 | |||||||||||||||||||
| Other non-cash expenses, net | 7 | 43 | 16 | 87 | |||||||||||||||||||
| Changes in operating assets and liabilities, net | 319 | (200) | 300 | 75 | |||||||||||||||||||
| Net cash used in operating activities | (1,322) | (1,379) | (4,960) | (4,086) | |||||||||||||||||||
| Cash flows from investing activities: | |||||||||||||||||||||||
| Purchase of held-to-maturity investments | — | (2,964) | — | (2,964) | |||||||||||||||||||
| Maturity of held-to-maturity investment | — | — | 1,000 | — | |||||||||||||||||||
| Purchase of property and equipment | (18) | (42) | (18) | (125) | |||||||||||||||||||
| Net cash provided by (used in) investing activities | (18) | (3,006) | 982 | (3,089) | |||||||||||||||||||
| Cash flows from financing activities: | |||||||||||||||||||||||
| Proceeds from the exercise of warrants, net | — | 5,622 | — | 10,482 | |||||||||||||||||||
| Proceeds from issuances of common stock, net | 227 | — | 400 | 2,706 | |||||||||||||||||||
| Repayments of notes payable | (16) | (14) | (46) | (42) | |||||||||||||||||||
| Net cash provided by financing activities | 211 | 5,608 | 354 | 13,146 | |||||||||||||||||||
| Increase (decrease) in cash and cash equivalents | (1,129) | 1,223 | (3,624) | 5,971 | |||||||||||||||||||
| Cash and cash equivalents, beginning of period | 5,080 | 6,055 | 7,575 | 1,307 | |||||||||||||||||||
| Cash and cash equivalents, end of period | $ | 3,951 | $ | 7,278 | $ | 3,951 | $ | 7,278 | |||||||||||||||
7
SENESTECH, INC.
Itemized Reconciliation Between Net Loss and Adjusted EBITDA (non-GAAP)
(In thousands)
(Unaudited)
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Net loss (as reported, GAAP) | $ | (1,956) | $ | (1,298) | $ | (5,851) | $ | (4,579) | |||||||||||||||
| Non-GAAP adjustments: | |||||||||||||||||||||||
| Stock-based and non-cash compensation | 524 | 18 | 757 | 299 | |||||||||||||||||||
| Severance costs | — | — | 503 | 27 | |||||||||||||||||||
| One-time legal costs | — | 111 | 217 | 356 | |||||||||||||||||||
| Interest income, net | (35) | (49) | (121) | (45) | |||||||||||||||||||
| Depreciation expense | 32 | 29 | 94 | 103 | |||||||||||||||||||
| Non-cash operating lease expense | 7 | 49 | 22 | 87 | |||||||||||||||||||
| Total non-GAAP adjustments | 528 | 158 | 1,472 | 827 | |||||||||||||||||||
| Adjusted EBITDA loss (non-GAAP) | $ | (1,428) | $ | (1,140) | $ | (4,379) | $ | (3,752) | |||||||||||||||
8